Abiomed (ABMD)

Abiomed (ABMD) Stock Price & Analysis


ABMD Stock Chart & Stats

Day’s Range$380.51 - $381.28
52-Week Range― - ―
Previous Close$380.79
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding45,091,184
10 Day Avg. Volume2,437,977
30 Day Avg. Volume1,565,041
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)12.13
Price to Sales (P/S)21.14
Price to Cash Flow (P/CF)60.80
P/FCF Ratio79.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-4.99% Downside
Rating ConsensusHold
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Abiomed’s price range in the past 12 months?
Currently, no data Available
What is Abiomed’s market cap?
Currently, no data Available
When is Abiomed’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Abiomed’s earnings last quarter?
Currently, no data Available
Is Abiomed overvalued?
According to Wall Street analysts Abiomed’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Abiomed pay dividends?
    Abiomed does not currently pay dividends.
    What is Abiomed’s EPS estimate?
    Abiomed’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Abiomed have?
    Currently, no data Available
    What happened to Abiomed’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Abiomed?
    Among the largest hedge funds holding Abiomed’s share is PRIMECAP Management Co. It holds Abiomed’s shares valued at 370M.


      Abiomed Stock Smart Score

      The Abiomed stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description


      ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Baxter International
      Zimmer Biomet Holdings

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis